Chemtrade Logistics Income Fund (CHE-UN) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
7 Apr, 2026Executive summary
2025 was a record year, achieving record Adjusted EBITDA of $507.4 million (up 7.8%) and record revenue of $1,997.8 million (up 11.8%), driven by strong operational execution, strategic acquisitions in Water and Ultrapure Acid, and robust results across key segments.
Expanded Water segment through acquisitions of Polytec and Thatcher Group assets for $180 million, supporting inorganic growth.
Optimized capital structure and returned $100.8 million to unitholders via distributions and unit repurchases in 2025.
Net earnings for 2025 increased to $139.4 million, supported by higher Adjusted EBITDA, FX gains, and lower tax/disposal losses.
Cash flows from operating activities increased 3.8% to $355.1 million; distributable cash after maintenance capex rose 7.0% to $228.0 million ($1.99/unit).
Financial highlights
Full-year 2025 revenue rose 12% year-over-year to $1,997.8 million; Q4 2025 revenue up 12% to $502.0 million.
Adjusted EBITDA for 2025 reached $507.4 million, up 8% year-over-year; Q4 Adjusted EBITDA declined 10% to $98.2 million.
Net earnings for 2025 increased 10% to $139.4 million; Q4 net earnings up 272% to $38.3 million.
Distributable cash after maintenance capex for 2025 was $228.0 million, up 7% year-over-year; per unit $1.99.
Net debt at year-end 2025 was $1,180.3 million, with a net debt to Adjusted EBITDA ratio of 2.3x.
Outlook and guidance
2026 Adjusted EBITDA guidance set at $485–$525 million, reflecting normalization of acid prices and increased maintenance activity.
2026 maintenance capex expected at $120–$150 million; growth capex at $35–$55 million.
Vision 2030 targets 5–10% annual growth in Adjusted EBITDA, aiming for $550–$600 million mid-cycle by 2030.
Q2 and Q3 2026 are expected to be the strongest quarters, though Q2 will be negatively impacted by the North Vancouver turnaround.
Caustic soda pricing is expected to recover in the second half of 2026, with fundamentals supporting a positive long-term trend.
Latest events from Chemtrade Logistics Income Fund
- Revenue up 16.5%, Adjusted EBITDA down 7.8%; 2026 guidance flat, H2 recovery expected.CHE-UN
Q2 2026 - Strong growth, disciplined capital returns, and robust 2026 outlook amid market volatility.CHE-UN
Investor presentation - Revenue up 7.9% to $503M, but Adjusted EBITDA down 5.5%; 2026 guidance reaffirmed.CHE-UN
Q1 2026 - Raised 2025 EBITDA guidance and ambitious growth targets drive strong returns and expansion.CHE-UN
Investor presentation - Record 2025 results and Vision 2030 target strong growth in water and ultrapure acid.CHE-UN
Investor presentation - Record earnings and robust growth driven by water treatment expansion and disciplined capital returns.CHE-UN
Investor presentation - Raised 2025 EBITDA guidance and announced Polytec acquisition to drive long-term growth.CHE-UN
Investor presentation - Raised 2024 Adjusted EBITDA guidance to $445–$460M after resilient Q3 and strong cash flow.CHE-UN
Q3 2024 - Raised 2024 Adjusted EBITDA guidance to $430–$460M after strong Q2 and mixed segment results.CHE-UN
Q2 2024